Skip to main content
. 2019 Jun 17;5(4):227–239. doi: 10.1002/cjp2.137

Figure 2.

Figure 2

EBV and MSI status of pre‐therapeutic biopsies and response to neoadjuvant CTx. Comparison of the four molecular subgroups with response to neoadjuvant CTx is shown. *P value of Chi‐square test each compared with MSS/EBV(−). Significant value in bold. One tumour biopsy from a responding patient (TRG1) was positive for both MSI‐L and EBV, and was excluded from analysis.